Business Context and Reporting Period
This Form 8-K Current Report was filed by Emerald Bioscience, Inc. (formerly Nemus Bioscience, Inc.) on March 25, 2019. The report documents a corporate name change and the associated update to the company's stock trading symbol.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and administrative changes rather than financial performance.
Material Changes
- Corporate Name: The company changed its name from Nemus Bioscience, Inc. to Emerald Bioscience, Inc., effective March 25, 2019.
- Stock Symbol: The Financial Industry Regulatory Authority (FINRA) assigned the new stock symbol "EMBI," which became effective at the open of business on March 25, 2019.
- Legal Documentation: A Certificate of Amendment to the Articles of Incorporation was filed to formalize the name change.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding financial guidance, future outlook, risks, contingencies, or unusual items. The document is limited to the announcement of the name and symbol change.
Investor Verification Checklist
- Verify the new stock ticker symbol "EMBI" on trading platforms.
- Confirm the effective date of the name change (March 25, 2019) for historical data tracking.
- Review the attached Certificate of Amendment (Exhibit 3.1) for details on the Articles of Incorporation.
- Check the press release (Exhibit 99.1) for any additional strategic context not included in the 8-K text.